Last reviewed · How we verify

NCT07257874

Intraoperative Pectoral Block vs IV Analgesia for Pain After Modified Radical Mastectomy

Active, enrolled Phase 3 Last updated 2 December 2025
What this trial tests

Phase 3 trial testing bupivacaine 0.5% injection in Mastectomy, Modified Radical in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 July 2025
Primary endpoint
10 December 2025
15 December 2025

Quick facts

Lead sponsorIslamabad Medical and Dental College
PhasePhase 3
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment60
Start date1 July 2025
Primary completion10 December 2025
Estimated completion15 December 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Islamabad Medical and Dental College

Who can join

Adults 18 to 65, female only, with Mastectomy, Modified Radical. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is difference in post operative pain between patients receiving inter- pectoral block and those receiving standard Intravenous analgesia(INJ TORADOL) in patients undergoing Modified Radical Mastectomy. To compare between these two methods , which one is better for post operative pain management.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of bupivacaine 0.5% injection

Trials testing the same drug.

Other Islamabad Medical and Dental College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07257874.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing